COMBINATION CHEMOTHERAPY INCLUDING EPIRUBICIN FOR THE MANAGEMENT OF NON-HODGKINS-LYMPHOMA

被引：26

作者：

ALISMAIL, SAD

WHITTAKER, JA

GOUGH, J

机构：

[1] W GLAMORGAN HLTH AUTHOR,DEPT HAEMATOL,SWANSEA,WALES

[2] UNIV WALES COLL MED,DEPT HAEMATOL,CARDIFF CF4 4XN,S GLAM,WALES

[3] UNIV WALES COLL MED,DEPT PATHOL,CARDIFF CF4 4XN,S GLAM,WALES

来源：

EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY | 1987年 / 23卷 / 09期

关键词：

D O I：

10.1016/0277-5379(87)90123-4

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1379 / 1384

页数：6

共 24 条

[1] SYSTOLIC-TIME INTERVAL AS INDEX OF SCHEDULE - DEPENDENT DOXORUBICIN CARDIOTOXICITY IN PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA
ALISMAIL, SAD
WHITTAKER, JA
[J]. BRITISH MEDICAL JOURNAL, 1979, 1 (6175) : 1392 - 1395
[2] ANDERSON T, 1977, CANCER TREAT REP, V61, P1057
[3] [Anonymous], 1982, CANCER, V49, P2112
[4] ARMITAGE P, 1971, STATISTICAL METHODS
[5] BAMBILA C, 1986, CANCER TREAT REP, V70, P262
[6] BILINGHAM ME, IN PRESS PROG ANTHRA
[7] DEVITA VT, 1975, LANCET, V1, P248
[8] ELIAS L, 1978, CANCER, V42, P1705, DOI 10.1002/1097-0142(197810)42:4<1705::AID-CNCR2820420408>3.0.CO
[9] 2-P
[10] 4'-EPI-DOXORUBICIN, A NEW ANALOG OF DOXORUBICIN - A PRELIMINARY OVERVIEW OF PRE-CLINICAL AND CLINICAL-DATA
GANZINA, F
[J]. CANCER TREATMENT REVIEWS, 1983, 10 (01) : 1 - 22